Don Nicholson

Chief Executive Officer at Nimbus Apollo, Inc.

Don Nicholson

Don Nicholson

Chief Executive Officer at Nimbus Apollo, Inc.

Overview
Career Highlights

Disc Medicine
Nimbus Apollo, Inc.
Nimbus Therapeutics LLC

RelSci Relationships

289

Number of Boards

6

Relationships
RelSci Relationships are individuals Don Nicholson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Rodin Therapeutics, Inc.

Relationship likelihood: Strong

Advisor at Atlas Venture, Inc.

Relationship likelihood: Strong

Director, Chief Executive Officer & President at Schrödinger, Inc.

Relationship likelihood: Strong

General Partner at Lilly Ventures Management Co. LLC

Relationship likelihood: Strong

Executive Director, Venture Capital at Pfizer, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Head, Nimbus ACC at Nimbus Therapeutics LLC

Relationship likelihood: Strong

Co-Founder at Disc Medicine

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Nimbus Therapeutics LLC

Relationship likelihood: Strong

Chairman at Generation Bio Co.

Relationship likelihood: Strong

Paths to Don Nicholson
Potential Connections via
Relationship Science
You
Don Nicholson
Chief Executive Officer at Nimbus Apollo, Inc.
Education

The University of Western Ontario, which is commonly referred to among Canadian universities as Western, is a public research university located in London, Ontario, Canada. The university's main campus covers 455 hectares (1,120 acres) of land, with the Thames River running through the eastern portion. The university was founded on 7 March 1878 by Bishop Isaac Hellmuth of the Anglican Diocese of Huron as "The Western University of London Ontario." It incorporated Huron University College, which had been founded in 1863.

Career History
Chief Executive Officer
Current

Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA.

Executive Chairman
Current

Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA.

Advisor
Current

Atlas Venture focuses on investments in early-stage companies operating in the fields of biotechnology. The firm partners with entrepreneurs to build companies around innovative science.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Don Nicholson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Don Nicholson's profile does not indicate a business or promotional relationship of any kind between RelSci and Don Nicholson.